# ICU Medical Inc: Form 10-K for the period ended Dec 31, 2012

- Company: [ICU Medical Inc](/companies/icui.md) (CIK 883984)
- Form: 10-K
- Filed: 2013-02-26
- Accepted by EDGAR: Feb 26, 2013, 14:34 ET
- Period: 2012-12-31
- Accession: 0000883984-13-000016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/883984/000088398413000016/icui1231201210-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/883984/000088398413000016/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-10-01 to 2012-12-31 | $82.7m | us-gaap:Revenues |
| Revenue | 12 months, 2012-01-01 to 2012-12-31 | $316.9m | us-gaap:Revenues |
| Cost of revenue | 12 months, 2012-01-01 to 2012-12-31 | $160.4m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-10-01 to 2012-12-31 | $41.8m | us-gaap:GrossProfit |
| Gross profit | 12 months, 2012-01-01 to 2012-12-31 | $156.5m | us-gaap:GrossProfit |
| Research and development | 12 months, 2012-01-01 to 2012-12-31 | $10.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2012-01-01 to 2012-12-31 | $84.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2012-01-01 to 2012-12-31 | $61.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2012-01-01 to 2012-12-31 | $20.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-10-01 to 2012-12-31 | $12.3m | us-gaap:NetIncomeLoss |
| Net income | 12 months, 2012-01-01 to 2012-12-31 | $41.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-10-01 to 2012-12-31 | $0.82 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months, 2012-01-01 to 2012-12-31 | $2.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-10-01 to 2012-12-31 | $0.86 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months, 2012-01-01 to 2012-12-31 | $2.90 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2012-01-01 to 2012-12-31 | 14,725,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2012-01-01 to 2012-12-31 | $66.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2012-01-01 to 2012-12-31 | $19.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2012-01-01 to 2012-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2012-12-31 | $146.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-12-31 | $325.5m | us-gaap:AssetsCurrent |
| Total assets | at 2012-12-31 | $428.5m | us-gaap:Assets |
| Current liabilities | at 2012-12-31 | $29.1m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2012-12-31 | $390.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/883984/000088398413000016/icui1231201210-k.htm

Filed Feb 26, 2013.
Source: SEC EDGAR, the filing index for accession 0000883984-13-000016. Last ingested by Listed: Nov 14, 2026, 20:54 ET. No prices; not investment advice.
